Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synergistic killing effects of PD-L1-CAR T cells and colorectal cancer stem cell-dendritic cell vaccine-sensitized T cells in ALDH1-positive colorectal cancer stem cells. | J Cancer | 2021 | 34659553 | PubTator, text mining | PubMed |
| Autoimmune Rheumatic Diseases and Vascular Function: The Concept of Autoimmune Atherosclerosis. | J Clin Med | 2021 | 34640445 | PubTator, text mining | PubMed |
| Overcoming Immune Resistance in Prostate Cancer: Challenges and Advances. | Cancers (Basel) | 2021 | 34638243 | PubTator, text mining | PubMed |
| EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression. | Cancer Biol Med | 2021 | 34633777 | PubTator, text mining | PubMed |
| Recent Advances in Experimental Dendritic Cell Vaccines for Cancer. | Front Oncol | 2021 | 34631558 | PubTator, text mining | PubMed |
| Identification of immunization-related new prognostic biomarkers for papillary renal cell carcinoma by integrated bioinformatics analysis. | BMC Med Genomics | 2021 | 34620162 | PubTator, text mining | PubMed |
| Fatty acid oxidation is a druggable gateway regulating cellular plasticity for driving metastasis in breast cancer. | Sci Adv | 2021 | 34613780 | PubTator, text mining | PubMed |
| Multifunctionality of Prostatic Acid Phosphatase in Prostate Cancer Pathogenesis. | Biosci Rep | 2021 | 34605872 | PubTator, text mining | PubMed |
| Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer. | Front Oncol | 2021 | 34595122 | PubTator, text mining | PubMed |
| Transient receptor potential vanilloid subtype 1 depletion mediates mechanical allodynia through cellular signal alterations in small-fiber neuropathy. | Pain Rep | 2021 | 34585035 | PubTator, text mining | PubMed |
| Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC). | Biomedicines | 2021 | 34572433 | PubTator, text mining | PubMed |
| Identification of key genes and immune infiltration modulated by CPAP in obstructive sleep apnea by integrated bioinformatics analysis. | PLoS One | 2021 | 34529670 | PubTator, text mining | PubMed |
| Spherical Nucleic Acid Vaccine Structure Markedly Influences Adaptive Immune Responses of Clinically Utilized Prostate Cancer Targets. | Adv Healthc Mater | 2021 | 34494382 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC). | J Immunother Cancer | 2021 | 34452927 | PubTator, text mining | PubMed |
| Simultaneous Engagement of Tumor and Stroma Targeting Antibodies by Engineered NK-92 Cells Expressing CD64 Controls Prostate Cancer Growth. | Cancer Immunol Res | 2021 | 34452926 | PubTator, text mining | PubMed |
| Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention. | Pharmaceutics | 2021 | 34452154 | PubTator, text mining | PubMed |
| Selective Moonlighting Cell-Penetrating Peptides. | Pharmaceutics | 2021 | 34452080 | PubTator, text mining | PubMed |
| Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies. | Biomolecules | 2021 | 34439738 | PubTator, text mining | PubMed |
| Bacterial Nosocomial Infections: Multidrug Resistance as a Trigger for the Development of Novel Antimicrobials. | Antibiotics (Basel) | 2021 | 34438992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=24